TY - JOUR
T1 - A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities
AU - Liu, Shouchun
AU - Zhou, Fanyu
AU - Höök, Magnus
AU - Carson, Daniel D.
PY - 1997/3/4
Y1 - 1997/3/4
N2 - We have previously identified and characterized a heparin-binding cell surface protein (heparin/heparan sulfate-interacting protein, or HIP) present on epithelial and endothelial cells. A synthetic peptide mimicking a heparin- binding domain of HIP is now shown to hind a small subset of heparin molecules with high affinity and, therefore, presumably recognizes a specific structural motif in the heparin molecule. Further analyses revealed that the heparin molecules exhibiting a high affinity for the HIP peptide also show an extremely high affinity for antithrombin III (AT-III), a cofactor required for heparin's anticoagulant activity. The HIP peptide was shown to compete with AT-III for binding to heparin and to neutralize the auticoagulant activity of heparin in blood plasma assays. Furthermore, the heparin subfraction that binds to the HIP peptide with high affinity exhibits an extremely high anticoagulant activity. We conclude that although the HIP peptide shows no sequence similarity with AT-III, the two proteins recognize the same or similar structural motifs in heparin.
AB - We have previously identified and characterized a heparin-binding cell surface protein (heparin/heparan sulfate-interacting protein, or HIP) present on epithelial and endothelial cells. A synthetic peptide mimicking a heparin- binding domain of HIP is now shown to hind a small subset of heparin molecules with high affinity and, therefore, presumably recognizes a specific structural motif in the heparin molecule. Further analyses revealed that the heparin molecules exhibiting a high affinity for the HIP peptide also show an extremely high affinity for antithrombin III (AT-III), a cofactor required for heparin's anticoagulant activity. The HIP peptide was shown to compete with AT-III for binding to heparin and to neutralize the auticoagulant activity of heparin in blood plasma assays. Furthermore, the heparin subfraction that binds to the HIP peptide with high affinity exhibits an extremely high anticoagulant activity. We conclude that although the HIP peptide shows no sequence similarity with AT-III, the two proteins recognize the same or similar structural motifs in heparin.
UR - http://www.scopus.com/inward/record.url?scp=0031055124&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031055124&partnerID=8YFLogxK
U2 - 10.1073/pnas.94.5.1739
DO - 10.1073/pnas.94.5.1739
M3 - Article
C2 - 9050848
AN - SCOPUS:0031055124
SN - 0027-8424
VL - 94
SP - 1739
EP - 1744
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 5
ER -